Log In
Print
BCIQ
Print
Print this Print this
 

Breast cancer vaccine (Ad5[E1-, E2b-]-HER2/neu)

  Manage Alerts
Collapse Summary General Information
Company Etubics Corp.
DescriptionVaccine using an adenovirus serotype 5 (Ad5) vector against HER2
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationBreast cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today